Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (38685) 38685
Newsletter (3174) 3174
Newspaper Article (1532) 1532
Book Chapter (522) 522
Magazine Article (205) 205
Book / eBook (71) 71
Transcript (64) 64
Dissertation (33) 33
Web Resource (17) 17
Conference Proceeding (16) 16
Publication (14) 14
Reference (14) 14
Government Document (5) 5
Trade Publication Article (4) 4
Paper (3) 3
Journal / eJournal (2) 2
Streaming Video (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31779) 31779
science & technology (20464) 20464
life sciences & biomedicine (19994) 19994
male (18685) 18685
female (17968) 17968
adult (15148) 15148
middle aged (13775) 13775
non-hodgkin's lymphomas (11113) 11113
oncology (10531) 10531
aged (9523) 9523
biological and medical sciences (9059) 9059
medical sciences (9006) 9006
adolescent (7574) 7574
hematology (7358) 7358
lymphoma (7248) 7248
cancer (6927) 6927
hodgkin disease - drug therapy (6871) 6871
antineoplastic combined chemotherapy protocols - therapeutic use (6489) 6489
chemotherapy (5874) 5874
prognosis (5545) 5545
hodgkin disease - therapy (5432) 5432
care and treatment (5327) 5327
hematologic and hematopoietic diseases (4924) 4924
lymphoma, non-hodgkin - drug therapy (4919) 4919
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (4741) 4741
hodgkin disease - radiotherapy (4607) 4607
child (4500) 4500
hodgkin disease - pathology (4469) 4469
treatment outcome (4459) 4459
hodgkin's disease (4405) 4405
research (4286) 4286
abridged index medicus (4281) 4281
t cells (3963) 3963
combined modality therapy (3648) 3648
lymphomas (3532) 3532
lymphoma, non-hodgkin - therapy (3457) 3457
retrospective studies (3326) 3326
lymphoma, non-hodgkin - pathology (3322) 3322
neoplasm staging (3307) 3307
antineoplastic agents (3056) 3056
aged, 80 and over (2831) 2831
follow-up studies (2730) 2730
tumors (2696) 2696
risk factors (2637) 2637
antineoplastic agents - therapeutic use (2609) 2609
non-hodgkin's lymphoma (2540) 2540
radiotherapy (2351) 2351
health aspects (2339) 2339
child, preschool (2321) 2321
vincristine - administration & dosage (2321) 2321
pharmacology. drug treatments (2264) 2264
drug therapy (2142) 2142
disease-free survival (2133) 2133
hodgkin disease - complications (2133) 2133
hodgkin disease - diagnosis (2119) 2119
young adult (2111) 2111
transplantation (2100) 2100
time factors (2093) 2093
doxorubicin - administration & dosage (2074) 2074
hemic and lymphatic diseases (2071) 2071
medicine & public health (2049) 2049
prednisone - administration & dosage (2049) 2049
hodgkin disease - mortality (2033) 2033
antineoplastic combined chemotherapy protocols - adverse effects (2024) 2024
analysis (2017) 2017
survival rate (2017) 2017
non-hodgkin lymphoma (2001) 2001
recurrence (1992) 1992
cyclophosphamide - administration & dosage (1988) 1988
patients (1975) 1975
medical research (1935) 1935
hodgkin lymphoma (1929) 1929
survival analysis (1874) 1874
leukemia (1854) 1854
animals (1771) 1771
diagnosis (1769) 1769
lymphoma, non-hodgkin - mortality (1763) 1763
remission induction (1757) 1757
antineoplastic combined chemotherapy protocols - administration & dosage (1738) 1738
lymphoma, non-hodgkin - diagnosis (1657) 1657
immunology (1653) 1653
rituximab (1593) 1593
pathology (1527) 1527
immunotherapy (1511) 1511
medicine, experimental (1486) 1486
stem cells (1452) 1452
biopsy (1439) 1439
diagnosis, differential (1397) 1397
transplantation, autologous (1358) 1358
radiotherapy dosage (1351) 1351
lymphoma, non-hodgkin - complications (1345) 1345
hodgkin disease (1313) 1313
clinical trials (1285) 1285
tomography, x-ray computed (1245) 1245
antimitotic agents (1244) 1244
bleomycin - administration & dosage (1244) 1244
immune system diseases (1244) 1244
vincristine - therapeutic use (1230) 1230
lymphoma, non-hodgkin - radiotherapy (1221) 1221
prednisone - therapeutic use (1216) 1216
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (30) 30
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Online Resources - Online (9) 9
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (9) 9
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (40152) 40152
German (1187) 1187
French (909) 909
Russian (773) 773
Japanese (378) 378
Italian (343) 343
Polish (340) 340
Spanish (317) 317
Chinese (156) 156
Portuguese (109) 109
Czech (98) 98
Hungarian (77) 77
Dutch (72) 72
Serbian (31) 31
Romanian (27) 27
Danish (26) 26
Norwegian (26) 26
Turkish (26) 26
Hebrew (20) 20
Croatian (18) 18
Finnish (18) 18
Swedish (12) 12
Korean (10) 10
Slovak (10) 10
Bulgarian (8) 8
Ukrainian (5) 5
Persian (4) 4
Lithuanian (2) 2
Afrikaans (1) 1
Bosnian (1) 1
Breton (1) 1
Galician (1) 1
Manx (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Medical management of hematological malignant diseases
by Freireich, Emil J and Kantarjian, Hagop
1998, Basic and clinical oncology, ISBN 9780824798864, Volume 14., ix, 572
Leukemia | Lymphomas | Treatment
Book
Details down arrow
2. Advances in malignant hematology
by Saba, Hussain I and Mufti, G. J
2011, 1. Aufl., ISBN 9781444393996, xxi, 416
Leukemia, Lymphoid | Leukemia, Myeloid | Leukemia | therapy | Lymphomas | metabolism | Myelodysplastic syndromes
Book
Details down arrow
3. Full Text Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
by Siegel, Corey A and Marden, Sadie M and Persing, Sarah M and Larson, Robin J and Sands, Bruce E
Clinical gastroenterology and hepatology, ISSN 1542-3565, 2009, Volume 7, Issue 8, pp. 874 - 881
Gastroenterology and Hepatology | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Lymphoma - epidemiology | Humans | Middle Aged | Risk Factors | Male | Crohn Disease - complications | Incidence | Young Adult | Animals | Crohn Disease - drug therapy | Adult | Female | Aged | Immunologic Factors - adverse effects | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Immunologic Factors - therapeutic use | Care and treatment | Cytogenetics | Crohn's disease | Non-Hodgkin's lymphomas | Drug therapy | Necrosis | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Celiac Disease: From Pathogenesis to Novel Therapies
by Schuppan, Detlef and Junker, Yvonne and Barisani, Donatella
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2009, Volume 137, Issue 6, pp. 1912 - 1933
Gastroenterology and Hepatology | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Glutens - immunology | Severity of Illness Index | T-Lymphocyte Subsets - immunology | Predictive Value of Tests | Genetic Predisposition to Disease | Immunotherapy - methods | Lymphoma, T-Cell - immunology | Celiac Disease - genetics | Immunity, Innate - drug effects | Humans | Risk Factors | Treatment Outcome | HLA Antigens - genetics | Intestinal Mucosa - drug effects | Celiac Disease - diagnosis | Animals | Celiac Disease - immunology | Intestinal Mucosa - immunology | Lymphoma, T-Cell - therapy | T-Lymphocyte Subsets - drug effects | Gastrointestinal Agents - therapeutic use | Celiac Disease - therapy | Diet, Gluten-Free | Disease Models, Animal | Autoimmunity | Medical colleges | Autoantibodies | HLA histocompatibility antigens | Permeability | Non-Hodgkin's lymphomas | Transforming growth factors | T cells | Biological response modifiers | Proteins | Celiac disease | Histocompatibility antigens | Proteases | Gastrointestinal diseases | Transglutaminases | Antigenic determinants | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
by Gooley, Ted A and Chien, Jason W and Pergam, Steven A and Hingorani, Sangeeta and Sorror, Mohamed L and Boeckh, Michael and Martin, Paul J and Sandmaier, Brenda M and Marr, Kieren A and Appelbaum, Frederick R and Storb, Rainer and McDonald, George B
The New England journal of medicine, ISSN 0028-4793, 11/2010, Volume 363, Issue 22, pp. 2091 - 2101
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | General aspects | Medical sciences | Epidemiology | Recurrence | Graft vs Host Disease - epidemiology | Multiple Myeloma - mortality | Humans | Middle Aged | Child, Preschool | Infant | Hematopoietic Stem Cell Transplantation - mortality | Infection - etiology | Lung Diseases - etiology | Transplantation, Homologous - mortality | Young Adult | Multiple Myeloma - therapy | Myelodysplastic Syndromes - therapy | Infection - epidemiology | Graft vs Host Disease - mortality | Bone Marrow Diseases - therapy | Kidney Diseases - epidemiology | Liver Diseases - etiology | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Child | Bone Marrow Diseases - mortality | Leukemia - therapy | Mortality - trends | Liver Diseases - epidemiology | Bilirubin - blood | Lymphoma, Non-Hodgkin - therapy | Adolescent | Creatinine - blood | Aged | Lymphoma, Non-Hodgkin - mortality | Kidney Diseases - etiology | Lung Diseases - epidemiology | Leukemia - mortality | United States | Mortality | Patient outcomes | Graft versus host reaction | Transplantation | Risk factors | Hematopoietic stem cells | Cytomegalovirus | Fungal infections | Nosocomial infections | Transplants & implants | Drug dosages | Index Medicus | Abridged Index Medicus | comparative outcomes research | ursodiol | liver disease | hematopoietic cell transplantation | pulmonary disease | Marrow transplantation | survival | mortality | kidney disease | graft-vs.-host disease | infectious complications
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Interim positron emission tomography response-adapted therapy in advanced-stage hodgkin lymphoma: Final results of the phase II part of the HD0801 study
by Zinzani, Pier Luigi and Broccoli, Alessandro and Gioia, Daniela Maria and Castagnoli, Antonio and Ciccone, Giovannino and Evangelista, Andrea and Santoro, Armando and Ricardi, Umberto and Bonfichi, Maurizio and Brusamolino, Ercole and Rossi, Giuseppe and Anastasia, Antonella and Zaja, Francesco and Vitolo, Umberto and Pavone, Vincenzo and Pulsoni, Alessandro and Rigacci, Luigi and Gaidano, Gianluca and Stelitano, Caterina and Salvi, Flavia and Rusconi, Chiara and Tani, Monica and Freilone, Roberto and Pregno, Patrizia and Borsatti, Eugenio and Sacchetti, Gian Mauro and Argnani, Lisa and Levis, Alessandro
Journal of clinical oncology, ISSN 0732-183X, 04/2016, Volume 34, Issue 12, pp. 1376 - 1385
Life Sciences & Biomedicine | Oncology | Science & Technology | Hodgkin Disease - diagnostic imaging | Predictive Value of Tests | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Positron-Emission Tomography | Patient Selection | Young Adult | Time Factors | Hodgkin Disease - mortality | Adult | Female | Stem Cell Transplantation - mortality | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Disease Progression | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Italy | Aged | Drug Substitution | Neoplasm Staging | Stem Cell Transplantation - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma
by Radford, John and Illidge, Tim and Counsell, Nicholas and Hancock, Barry and Pettengell, Ruth and Johnson, Peter and Wimperis, Jennie and Culligan, Dominic and Popova, Bilyana and Smith, Paul and McMillan, Andrew and Brownell, Alison and Kruger, Anton and Lister, Andrew and Hoskin, Peter and O’Doherty, Michael and Barrington, Sally
The New England journal of medicine, ISSN 0028-4793, 04/2015, Volume 372, Issue 17, pp. 1598 - 1607
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Doxorubicin - therapeutic use | Recurrence | Follow-Up Studies | Dacarbazine - therapeutic use | Humans | Middle Aged | Proportional Hazards Models | Male | Combined Modality Therapy | Positron-Emission Tomography | Vinblastine - therapeutic use | Disease Progression | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Aged | Neoplasm Staging | Medical research | Scanning | Vinblastine | Leukemia | Radiation therapy | Lymphoma | Doxorubicin | Survival | Patients | Dacarbazine | Chemotherapy | Bleomycin | Medical prognosis | Positron emission tomography | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights